Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Sirenia Capital Management LP reported a 5.30% stake in Dianthus Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Sirenia Capital Management LP reported a 5.30% stake in Dianthus Therapeutics, Inc., 2,798,122 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.30%
- Shares
- 2,798,122
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sirenia Capital Management LP | 5.30% | 2,798,122 |
| Alex Silverstein | 5.30% | 2,798,122 |
Source
Related
- Dianthus Therapeutics, Inc.
- Sirenia Capital Management LP
- Dianthus Therapeutics, Inc. shareholders
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026